Advisor Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$267K Buy
8,344
+396
+5% +$14.6K 0.02% 685
2022
Q1
$250K Buy
7,948
+259
+3% +$8.1K 0.02% 734
2021
Q4
$259K Sell
7,689
-63
-0.8% -$1.96K 0.02% 730
2021
Q3
$225K Buy
7,752
+122
+2% +$3.95K 0.02% 725
2021
Q2
$266K Buy
7,630
+255
+3% +$8.44K 0.02% 690
2021
Q1
$206K Buy
+7,375
New +$196K 0.01% 765
2019
Q2
Sell
-8,503
Closed -$316K 654
2019
Q1
$316K Buy
8,503
+141
+2% +$5.13K 0.04% 432
2018
Q4
$236K Buy
8,362
+1,014
+14% +$32.1K 0.04% 481
2018
Q3
$290K Sell
7,348
-74
-1% -$3.24K 0.04% 459
2018
Q2
$329K Buy
7,422
+43
+0.6% +$2.14K 0.06% 389
2018
Q1
$359K Sell
7,379
-1,010
-12% -$50.5K 0.07% 344
2017
Q4
$453K Sell
8,389
-680
-7% -$35.6K 0.08% 291
2017
Q3
$459K Sell
9,069
-158
-2% -$7.45K 0.09% 243
2017
Q2
$350K Sell
9,227
-594
-6% -$23.4K 0.08% 303
2017
Q1
$378K Buy
9,821
+140
+1% +$4.21K 0.1% 255
2016
Q4
$214K Buy
+9,681
New +$199K 0.06% 372
2016
Q3
Sell
-12,156
Closed -$100K 406
2016
Q2
$100K Buy
12,156
+580
+5% +$5.17K 0.04% 374
2016
Q1
$81K Buy
+11,576
New +$58.2K 0.03% 355

Other funds holding CC

Advisor Partners's CC Position: Q2 2022 in Review

Advisor Partners increased its Chemours (CC) stake by 5% in Q2 2022, buying an estimated $14.6K and bringing the position to 8,344 shares worth $267K. The position accounts for 0.02% of the portfolio, ranked #685.

Advisor Partners first reported a position in CC in Q1 2016 and has held it in 18 quarters since. The position peaked at $459K in Q3 2017. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

  • Advisor Partners held 8,344 shares of Chemours worth $267K as of Q2 2022.
  • Advisor Partners bought 396 Chemours shares in Q2 2022, an estimated $14.6K.
  • Chemours made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #685 holding.
  • Advisor Partners first reported a position in Chemours in Q1 2016 and has held it in 18 quarters since.
  • Advisor Partners's Chemours position peaked at $459K in Q3 2017.
  • 517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.